BITE

Live / Registered — Registered and renewed (as of 28 Jun 2016)

What this means for you

Registered since 14 Mar 2006. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 14 Mar 2016).

Record

Serial number
78040636
Registration number
3068856
Mark type
Word mark
Filed
26 Dec 2000
Published for opposition
09 Sept 2003
Registered
14 Mar 2006
Next maintenance due
14 Mar 2016
Attorney of record
Elsa D. Lemoine

Goods and services

  • Class 005 — Pharmaceuticals: [ Medicaments, namely, polypeptides, particularly antibodies and antibody derivatives, for use in the treatment of tumorous diseases, allergies, autoimmunity, inflammation, infectious diseases, osteoporosis, graft versus host diseases, transplant rejection, coronary heart diseases, and minimal residual diseases, in the form of intravenous, sub-cutaneous, intra-peritoneal, intra-muscular and aerosol therapies ]
  • Class 035 — Advertising and business services: [ Human and veterinary services, namely, licensing of medicaments, namely, polypeptides, particularly antibodies and antibody derivatives, for use in the treatment of tumorous diseases, allergies, autoimmunity, inflammation, infectious diseases, osteoporosis, graft versus host disease, transplant rejection, coronary heart diseases, and minimal residual diseases; licensing of technology for the identification of tumorous diseases, allergies, autoimmunity, inflammation, infectious diseases, osteoporosis, graft versus host disease, transplant rejection, coronary heart diseases, and minimal residual diseases, and for the identification of expressed genes, particularly of abnormal expressed genes, for the analysis and identification of the gene expression pattern and eukaryotic cells, particularly of single cells and cell culture lines, particularly of mammalian and human cells, particularly of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples prepared with laser, of cells isolated with FACS or with receptor to ligand binding, of chemical fixed tissue, of micrometastatic cells, of bone marrow cells, of samples of body fluids, particularly from liquor, blood, lymph, urine or bowel movement, of stem cells, cloned single cells or differentiated stages from specific cells ]
  • Class 042 — Scientific and technological services: Medical services; laboratory research in the field of polypeptides, particularly antibodies and antibody derivatives; human and veterinary services, namely, product development, in the field of medicaments, namely, polypeptides, particularly antibodies and antibody derivatives, for use in the treatment of tumorous diseases, allergies, autoimmunity, inflammation, infectious diseases, osteoporosis, graft versus host disease, transplant rejection, coronary heart diseases and minimal residual diseases; product development, in the field of diagnostic and testing apparatus and instruments for the identification of tumorous diseases, allergies, autoimmunity, inflammation, infectious diseases, osteoporosis, graft versus host diseases, transplant rejection, coronary heart diseases, and minimal residual diseases, and for the identification of expressed genes, particularly of abnormal expressed genes, for the analysis and identification of the gene expression pattern and eukaryotic cells, particularly of single cells and cell culture lines, particularly of mammalian and human cells, particularly of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples prepared with laser, of cells isolated with FACS or with receptor to ligand binding, of chemical fixed tissue, of micrometastatic cells, of bone marrow cells, of samples of body fluids, particularly from liquor, blood, lymph, urine or bowel movement, of stem cells, cloned single cells or differentiated stages from specific cells

Owner

Prosecution history

  • 04 Mar 2026 — TEAS SECTION 8 & 9 RECEIVED
  • 14 Mar 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
  • 29 Apr 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
  • 29 Apr 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 29 Apr 2022 — TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
  • 29 Apr 2022 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
  • 29 Apr 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 29 Apr 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 29 Apr 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
  • 07 Mar 2019 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 07 Mar 2019 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 02 Aug 2018 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 02 Aug 2018 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 28 Jun 2016 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
  • 28 Jun 2016 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

View this trademark record on Marksy